Professional Documents
Culture Documents
**Authorization is hereby given to dispense the generic equivalent unless otherwise indicated by physician_____
Title: Therapeutic Heparin Protocol ACS/PCI
Specialty: MHS Pharmacy and Therapeutics Committee
Physician Orders: MHS P005348 (rev 01-20-16)
Page 1 of 2
Heparin (Preferred agent for patient on hemodialysis or CVVH)
Height:
(inches)
Allergies:
Weight:
(Kg)
Admission Status:
*POS*
MHS P005348
*Initiate all orders without checkboxes AND initiate orders with checkboxes only if checked
**Authorization is hereby given to dispense the generic equivalent unless otherwise indicated by physician_____
Title: Therapeutic Heparin Protocol ACS/PCI
Specialty: MHS Pharmacy and Therapeutics Committee
Physician Orders: MHS P005348 (rev 01-20-16)
Page 2 of 2
Dose Adjustments Acute Coronary Syndrome (ACS) or Percutaneous Coronary Intervention (PCI) Dosing
Adjust heparin infusion rate based on sliding scale listed below:
Rate Adjustment (round dose to the nearest 100 units)
Re-bolus 60 units/Kg (maximum 4,000 units) and increase infusion rate by 2 units/Kg/hr
Increase infusion rate by 2 units/Kg/hr
No change (therapeutic range)
Decrease infusion rate by 2 units/Kg/hr
Stop infusion, recheck PTT in 1 hour, follow algorithm based on repeat PTT
aPTT (seconds)
< 35 seconds
35 - 53 seconds
54-70 seconds
71-105 seconds
> 105 seconds
Labs
Labs Prior to Initiation of Heparin
Prothrombin Time (PT)
CBC without differential
Activated Partial Thromboplastin Time (aPTT) [Order in Meditech as PTT]
Note: if PTT result is desired DO NOT order PTT heparin Neutralization, instead order PTT
AM Labs
CBC without differential daily
Additional Orders
___________________________________________________________________________________________
___________________________________________________________________________________________
___________________________________________________________________________________________
_____________
Date (required)
_____________ ________________________
_____________________________________
Time (required) Physician Signature (required) Physician Printed Name First & Last (required)
Citation:
Garcia D, Baglin T, et al. Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis 9th Ed:
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest 2012, pages e24s-e43s
2014 AHA/ACC NSTE-ACS Guideline: A Report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines: 4.3.2.4. Unfractionated Heparin, page 45.
*POS*
MHS P005348